Breast Cancer (Therapy)

California Panel Concludes That Tamoxifen Is A Carcinogen

Published in Cancer Weekly, November 20th, 1995

A panel of state-appointed scientists has unanimously concluded that one of the world's most widely prescribed anti-cancer drugs, tamoxifen, can itself cause cancer.

This finding would normally mean that tamoxifen, which has been prescribed worldwide to about three million women with breast cancer, would be added to the State of California governor's list of 404 chemicals "known to the state to cause cancer."

But the drug has not been listed.

Instead, under pressure from the drug maker and the U.S. National Cancer Institute (NCI) and after personal intervention by the governor, the Wilson Administration has delayed a decision...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-11-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry